<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Bolon I</dc:creator>
  <dc:creator>Zhou HM</dc:creator>
  <dc:creator>Charron Y</dc:creator>
  <dc:creator>Wohlwend A</dc:creator>
  <dc:creator>Vassalli JD</dc:creator>
  <dc:date>2004</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Increased expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) is associated with different pathological conditions. Both uPAR-mediated signaling and plasmin-catalyzed extracellular proteolysis may contribute to pathogenesis. To evaluate the involvement of plasminogen in such circumstances, we have taken advantage of transgenic mouse models in which overexpression of uPA and/or uPAR in enamel epithelium, basal epidermis, and hair follicles leads to a pathological phenotype; uPA transgenic mice have chalky-white incisors and, when uPAR is co-expressed, develop extensive alopecia, epidermal thickening, and subepidermal blisters. We report here that when these transgenic mice were backcrossed into a plasminogen-deficient (Plg-/-) background, the dental and skin phenotypes appeared completely normal. Heterozygous Plg+/- transgenic mice exhibited a haplo-insufficiency, with an intermediate or normal phenotype. These results do not argue in favor of a role for uPAR-mediated signaling in our experimental model; rather, they demonstrate an essential, dose-dependent, requirement for plasminogen in uPA-mediated tissue alterations. They also support the hypothesis that plasminogen could play a part in certain skin diseases.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/5386</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/S0002-9440(10)63786-8</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/15161662</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>The American journal of pathology. - 2004</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Crosses, Genetic</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Dental Enamel</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Dental Enamel Hypoplasia</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Gene Expression Regulation</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Incisor</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Mice</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Mice, Inbred C57BL</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Mice, Inbred CBA</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Mice, Transgenic</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Phenotype</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Plasminogen</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Receptors, Cell Surface</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Receptors, Urokinase Plasminogen Activator</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Tooth Abnormalities</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Urokinase-Type Plasminogen Activator</dc:subject>
  <dc:title xmlns:ns17="xml" ns17:lang="en">Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpression.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
